Edity is programming the body’s own immune cells to carry therapeutics to places where treatment normally cannot reach

American physicians and German research institutes offer moral support as Israeli healthcare workers weigh whether to stay and fight for scientific freedom or relocate

Companies dealing in life sciences and technology face tougher times ahead due to global economic uncertainty and political crisis at home

But local life sciences industry proves more resilient than any other high-tech sector as firms raised $2.8 billion in 2022, IVC-aMoon report finds

CEOs and top researchers fear potential threat to democracy will jeopardize international partnerships that Israel's innovators rely on to bring treatments to market

Jerusalem-based Salignotics marks entry into global pregnancy testing market valued at nearly $2 billion by 2030

Company behind the tech says each gram of its product will stretch much further in treating patients than a gram from cannabis plant — and needs far less water and other resources

NGT's new fund hopes to capitalize on burgeoning output from Arab medical sector; in 20 years, Arab Israelis went from making up 11.2% of new physicians to nearly half

AION Labs, a Rehovot-based consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company that will help drug firms improve chances of success in clinical trials

Fed up with gender discrimination, founders are offering solutions to improve women’s lives, and investors are taking an interest